Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Sep;41(9):4009-15.
doi: 10.1128/JCM.41.9.4009-4015.2003.

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis

Melissa B Miller  1 , Peter H Gilligan
Affiliations
Review

Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis

Melissa B Miller et al. J Clin Microbiol. 2003 Sep.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Use of BCSA improves recovery of B. cepacia complex. (Left) MacConkey agar demonstrating overgrowth by a mucoid strain of P. aeruginosa; (right) BCSA showing the growth of B. cenocepacia (genomovar III) that cannot be visualized on the corresponding MacConkey agar.
See this image and copyright information in PMC

References

    1. Aaron, S. D., W. Ferris, K. Ramotar, K. Vandemheen, F. Chan, and R. Saginur. 2002. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis. J. Clin. Microbiol. 40:4172-4179. - PMC - PubMed
    1. Aris, R. M., J. C. Routh, J. J. LiPuma, D. G. Heath, and P. H. Gilligan. 2001. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am. J. Respir. Crit. Care Med. 164:2102-2106. - PubMed
    1. Arpi, M., M. A. Victor, I. Mortensen, A. Gottschau, and B. Bruun. 1996. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods. APMIS 104:108-114. - PubMed
    1. Burns, J. L., R. L. Gibson, S. McNamara, D. Yim, J. Emerson, M. Rosenfeld, P. Hiatt, K. McCoy, R. Castile, A. L. Smith, and B. W. Ramsey. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J. Infect. Dis. 183:444-452. - PubMed
    1. Burns, J. L., L. Saiman, S. Whittier, J. Krzewinski, Z. Liu, D. Larone, S. A. Marshall, and R. N. Jones. 2001. Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 39:257-260. - PubMed

MeSH terms